Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - TOTAL ASSETS
Total Assets REPL - Replimune Group, Inc.
488 M
LAST VALUE
2.84%
2 YEAR CAGR
25.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR